Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Infectious Disease Clinics of North America|January 6, 2001
Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testingN A Kartsonis, R T D'AquilaDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 10, 2003
Caspofungin: the first in a new class of antifungal agentsNicholas A Kartsonis, Jennifer Nielsen, Cameron M DouglasMedical Mycology|April 7, 2011
Efficacy and safety of caspofungin in obese patientsDesmond M Ryan, Robert J Lupinacci, Nicholas A KartsonisPeptides|September 1, 1991
Identification of RFamide neuropeptides in the medicinal leechB D Evans, J Pohl, N A Kartsonis, et al.The Journal of Infection|May 24, 2005
Invasive candidiasis in cancer patients: observations from a randomized clinical trialMark J DiNubile, Darcy Hille, Carole A Sable, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2007
Caspofungin in the treatment of symptomatic candiduriaJack D Sobel, Susan K Bradshaw, C Joy Lipka, et al.The Journal of Antimicrobial Chemotherapy|March 27, 2004
Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use studyNicholas A Kartsonis, Alfred Saah, C Joy Lipka, et al.International Journal of Antimicrobial Agents|September 20, 2011
Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief reportAngela L Ngai, Michael R Bourque, Robert J Lupinacci, et al.Journal of Critical Care|September 18, 2007
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trialMark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, et al.The Journal of Infection|March 23, 2005
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use studyNicholas A Kartsonis, Alfred J Saah, C Joy Lipka, et al.Pageof 4